CWM
GILD icon

Consultiva Wealth Management’s Gilead Sciences GILD Stock Holding History

Consultiva Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25K Hold
198
– – 0.06% 157
2026
Q1 		$27.6K Hold
198
– – 0.08% 130
2025
Q4 		$24.3K Hold
198
– – 0.07% 141
2025
Q3 		$22K Hold
198
– – 0.06% 154
2025
Q2 		$22K Hold
198
– – 0.07% 149
2025
Q1 		$22.2K Hold
198
– – 0.08% 148
2024
Q4 		$18.3K Buy
+198
New +$17.8K 0.09% 100

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Consultiva Wealth Management's GILD Position: Q2 2026 in Review

Consultiva Wealth Management held its Gilead Sciences (GILD) position steady in Q2 2026 at 198 shares worth $25K. The position accounts for 0.06% of the portfolio, ranked #157.

Consultiva Wealth Management first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $27.6K in Q1 2026. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Consultiva Wealth Management held 198 shares of Gilead Sciences worth $25K as of Q2 2026.
  • Consultiva Wealth Management left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.06% of Consultiva Wealth Management's portfolio in Q2 2026, its #157 holding.
  • Consultiva Wealth Management first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • Consultiva Wealth Management's Gilead Sciences position peaked at $27.6K in Q1 2026.
  • 2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Consultiva Wealth Management's 13F filing for Q2 2026, filed 13 Aug 2026.